Vitrafy Life Sciences signs U.S. cell and gene therapy charter deal
Vitrafy Life Sciences Ltd (VFY) entered the U.S. cell & gene therapy market via a charter medical agreement.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.